These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10867529)

  • 1. The unmasking of hyperreninemic hypovolemia by captopril test in a hypertensive HD patient unaccompanied by autonomic neuropathy.
    Kürşat S; Ozgür B; Yurtman G
    Nephron; 2000 Jun; 85(2):185-6. PubMed ID: 10867529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Captopril--an inhibitor of the angiotensin I converting enzyme--in the treatment of arterial hypertension in chronic kidney failure patients].
    Manasia M; Paţiu IM; Vlăduţiu D; Madi A; Barabas E; Gherman M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(3):217-22. PubMed ID: 2865784
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary hyperaldosteronism in a patient with end-stage renal disease.
    Kazory A; Weiner ID
    Nephrol Dial Transplant; 2007 Mar; 22(3):917-9. PubMed ID: 17127694
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic hypovolemia associated with accelerated hypertension and orthostatic hypotension in a patient on continuous ambulatory peritoneal dialysis.
    Touma T; Muratani H; Iseki K; Kawazoe N; Takishita S; Fukiyama K
    Am J Nephrol; 1992; 12(6):461-5. PubMed ID: 1292347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension in the uremic patient. Possible role of the autonomic system].
    Zuccalà A; Bolzani R; Chiarini C; Degli Esposti E; Gattiani A; Sturani A; Vecchi F; Zucchelli P
    Minerva Nefrol; 1979; 26(1):13-8. PubMed ID: 471317
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sympathetic and plasma renin activity on hemodialysis hypertension.
    Grekas D; Kalevrosoglou I; Karamouzis M; Geropoulou E; Kabouris H; Tourkantonis A
    Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic overactivity in hypertensive patients with chronic renal disease.
    Remuzzi G
    N Engl J Med; 1999 Apr; 340(17):1360-1. PubMed ID: 10219074
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y; Tharaux PL; Ragueneau I; Dussaule JC; Picker JL; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of severe arterial hypertension in patients with chronic kidney failure with captopril and beta-adrenoblockaders].
    Ermolenko VM; Lifshits NL; Zisel'man SB; Tatsievskiĭ VA
    Urol Nefrol (Mosk); 1991; (3):41-8. PubMed ID: 1871923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic component in hypertension accompanying renal failure.
    McGrath BP
    Contrib Nephrol; 1984; 41():83-9. PubMed ID: 6525873
    [No Abstract]   [Full Text] [Related]  

  • 13. [The mechanisms of the development of arterial hypertension in patients with chronic kidney failure treated by hemodialysis].
    Konstantinov IuV; Komandenko MS; Nikolaeva AA; D'iachuk MM
    Urol Nefrol (Mosk); 1993; (3):39-41. PubMed ID: 7941161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual captopril in hypertensive attacks in patients on hemodialysis.
    Coronel F; Horcajo P; Alvarez MJ; Torrente J; Rentero R
    Nephron; 1988; 49(4):339-40. PubMed ID: 3045685
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Captopril test', with blood pressure and peripheral renin as response variables in hypertensive patients with suspected renal artery stenosis.
    Schreij G; van Es PN; Schiffers PM; Lavrijssen AT; de Leeuw PW
    J Hum Hypertens; 1995 Sep; 9(9):741-6. PubMed ID: 8551488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The etiology of hypertension.
    Ledingham JM
    Practitioner; 1971 Jul; 207(237):5-19. PubMed ID: 4326682
    [No Abstract]   [Full Text] [Related]  

  • 17. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability of a standardized captopril-test in hypertension in end-stage renal failure.
    Schohn DC; Jahn HA; Schmitt RL
    Kidney Int Suppl; 1988 Sep; 25():S145-8. PubMed ID: 3054231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.